1. Introduction to PerkinElmer, Inc.

PerkinElmer, Inc. stands as a global leader in the healthcare and life sciences industry, renowned for its innovative diagnostic tools, analytical instruments, and software solutions that empower scientists, clinicians, and healthcare providers to solve the world's most pressing health challenges. Headquartered in Waltham, Massachusetts, the company operates across more than 150 countries, with a workforce exceeding 13,000 employees and annual revenues surpassing $3 billion. As a trusted partner in the healthcare ecosystem, PerkinElmer delivers end-to-end solutions ranging from early disease detection and newborn screening to advanced genomic analysis and environmental testing. Its reputation for precision, reliability, and cutting-edge technology makes it a cornerstone of modern healthcare infrastructure, relied upon by hospitals, research institutions, pharmaceutical companies, and government agencies worldwide. The company’s commitment to innovation is evident in its robust portfolio of patents, continuous investment in R&D, and strategic acquisitions that expand its capabilities in areas such as immunodiagnostics, reproductive health, and applied genomics. PerkinElmer’s market leadership is further validated by its inclusion in major indices like the S&P 500 and recognition as a top employer in the healthcare sector. For professionals seeking a dynamic environment where scientific excellence meets commercial impact, PerkinElmer offers unparalleled opportunities to shape the future of healthcare delivery and diagnostic accuracy.

2. Company History and Business Evolution

Founded in 1947 by Richard Perkin and Charles Elmer, PerkinElmer began as a small optical design and consulting firm in Norwalk, Connecticut. The company quickly gained prominence by producing high-precision lenses and mirrors for the U.S. military during the Cold War, and by the 1960s, it had expanded into scientific instrumentation, notably introducing the world's first commercial atomic absorption spectrophotometer. Throughout the 1970s and 1980s, PerkinElmer diversified through strategic acquisitions, entering the fields of analytical chemistry, environmental monitoring, and life sciences. A pivotal moment came in 1997 with the launch of the first automated DNA sequencer, which revolutionized genomics and set the stage for the company’s leadership in molecular diagnostics. The early 2000s saw a focused shift toward healthcare and diagnostics, marked by the acquisition of several diagnostic companies, including DRC (Diagnostic Reagents & Controls) and the Euroimmun group. In 2011, PerkinElmer acquired Caliper Life Sciences, strengthening its imaging and detection capabilities for drug discovery. More recently, the company has embraced digital transformation, integrating AI and machine learning into its platforms to enhance predictive analytics and personalized medicine. The 2020 acquisition of Horizon Discovery, a leader in gene editing and cell engineering, further solidified PerkinElmer’s position at the forefront of precision medicine. Today, the company continues to evolve, with a clear roadmap toward addressing global health disparities, expanding into emerging markets, and delivering integrated solutions that bridge diagnostics, informatics, and therapeutic development. This rich history of innovation and adaptability underscores PerkinElmer’s enduring commitment to advancing human health through science.

3. PerkinElmer, Inc. at a Glance

• Headquarters: Waltham, Massachusetts, USA
• Founded: 1947 by Richard Perkin and Charles Elmer
• CEO: Prahlad Singh (as of 2025)
• Revenue: Approximately $3.2 billion (FY2024)
• Employees: Over 13,000 worldwide
• Industry: Healthcare, Life Sciences, Diagnostics, Analytical Instruments
• Stock Symbol: PKI (NYSE)
• Global Presence: Operations in 150+ countries
• Key Products: Chemagic, SuperFlex, GSP, VICTOR, EnVision, and others
• Major Acquisitions: Euroimmun, Caliper Life Sciences, Horizon Discovery
• Innovation Focus: Genomics, Immunodiagnostics, Newborn Screening, Environmental Testing
• Awards: Consistently ranked among Fortune’s World’s Most Admired Companies
• R&D Investment: Over 8% of annual revenue allocated to research and development
• Patents: More than 5,000 active patents globally
• Customer Base: Hospitals, clinics, research labs, pharma, biotech, government agencies
• Corporate Responsibility: Sustainability initiatives, STEM education programs, community health projects
• ISO Certifications: ISO 9001, ISO 13485, ISO 14001
• Regulatory Compliance: FDA, CE marking, IVDR, CLIA
• Partnerships: Collaborations with WHO, CDC, and leading universities
• Key Competitors: Thermo Fisher Scientific, Agilent Technologies, Bio-Rad, Danaher, Roche Diagnostics

4. Mission, Vision, and Core Corporate Values

Mission: PerkinElmer’s mission is to enable scientists, clinicians, and healthcare providers to improve human health and protect the environment through innovative analytical and diagnostic solutions. The company strives to deliver actionable insights that drive better outcomes for patients and communities worldwide.

Vision: To be the global leader in diagnostic and life science technologies, creating a healthier, safer, and more sustainable world. PerkinElmer envisions a future where precision medicine is accessible to all, and environmental monitoring ensures the well-being of our planet.

Core Values: Innovation: Pioneering breakthroughs that transform healthcare and science. Integrity: Upholding the highest ethical standards in all operations. Impact: Delivering measurable results that improve lives. Collaboration: Fostering partnerships across disciplines and borders. Agility: Adapting rapidly to evolving customer needs and market dynamics. Inclusivity: Cultivating a diverse workforce that reflects the communities we serve. These values are embedded in every aspect of PerkinElmer’s culture, from product development to customer engagement, ensuring consistent excellence and trust.

5. Business Strategy and Future Roadmap

PerkinElmer’s business strategy centers on three pillars: Diagnostic Leadership, Life Sciences Innovation, and Operational Excellence. The company intends to drive growth by expanding its presence in high-growth diagnostic segments such as immunodiagnostics, molecular testing, and newborn screening, particularly in emerging markets where healthcare infrastructure is rapidly developing. In life sciences, PerkinElmer is investing heavily in gene editing, cell therapy, and multi-omics integration, leveraging its proprietary platforms to accelerate drug discovery and personalized treatment. The company’s future roadmap emphasizes digital transformation: embedding AI and cloud computing into its instruments and software to enable real-time data analysis and remote diagnostics. Additionally, PerkinElmer is pursuing strategic acquisitions that complement its core capabilities, such as the recent addition of CleanSpace to enhance environmental monitoring. Sustainability is also a key focus, with targets to reduce carbon footprint by 30% by 2030 and to develop eco-friendly products. The company aims to achieve mid-single-digit organic revenue growth annually while expanding margins through lean manufacturing and supply chain optimization. By 2028, PerkinElmer expects to generate over $4 billion in revenue, with significant contributions from Asia-Pacific and Latin America. This forward-looking strategy positions PerkinElmer to remain at the forefront of healthcare innovation while delivering consistent value to shareholders and society.

6. Products, Technologies, and Services

PerkinElmer offers a comprehensive portfolio spanning instruments, reagents, software, and services across the healthcare and life sciences spectrum. Key product lines include: Diagnostic Solutions – such as the GSP Neonatal screening system, SuperFlex immunoassay platform, and the EUROIMMUN product suite for autoimmune and infectious disease testing. Life Sciences Solutions – featuring the EnVision multimode plate reader, Operetta high-content imaging system, and the Chemagic automated nucleic acid extraction platforms. Software and Informatics – including the Signals chemistry software, TIBCO Spotfire data visualization, and the VICTOR Nivo multimode reader software. Environmental and Applied Solutions – such as the QSight triple quadrupole mass spectrometer for industrial and environmental testing. The company also provides a wide range of reagents, assay kits, and consumables that support both research and clinical workflows. Services include instrument maintenance, calibration, validation, and training programs, ensuring customers maximize uptime and productivity. PerkinElmer’s technologies are built on core competencies in detection, automation, and data analytics, enabling high-throughput, accurate results across diverse applications from prenatal screening to wastewater surveillance.

7. Industries and Markets Served

PerkinElmer serves multiple industries and markets, each benefiting from tailored solutions. The Healthcare and Clinical Diagnostics sector includes hospitals, reference laboratories, and point-of-care settings, relying on PerkinElmer for newborn screening, infectious disease testing, cancer diagnostics, and reproductive health. The Pharmaceutical and Biotechnology industry uses the company’s tools for drug discovery, preclinical development, and quality control. The Environmental Monitoring market leverages PerkinElmer’s analytical instruments to test water, soil, and air quality for contaminants, supporting regulatory compliance and public health. The Food and Beverage industry employs its systems for safety testing (e.g., aflatoxins, pesticides) and nutritional analysis. Academic and Government Research institutions utilize PerkinElmer’s advanced imaging and genomics platforms for basic and translational research. Additionally, the company serves Industrial and Material Science sectors with solutions for detecting trace elements and characterizing materials. This broad market reach provides stability and growth opportunities, while cross-sector innovations often find new applications, reinforcing PerkinElmer’s role as a versatile technology provider.

8. Leadership and Management Philosophy

PerkinElmer’s leadership team, led by CEO Prahlad Singh, emphasizes a people-first, innovation-driven management philosophy. Singh, who took the helm in 2020, has focused on streamlining operations, fostering a culture of accountability, and accelerating digital transformation. The executive team comprises seasoned leaders from diverse backgrounds in science, engineering, finance, and global business, reflecting the company’s commitment to inclusive leadership. The management philosophy is built on four principles: Empowerment – giving teams autonomy to make decisions and innovate; Transparency – open communication about strategy, performance, and challenges; Respect – treating all employees, customers, and partners with dignity; and Excellence – pursuing the highest standards in everything they do. PerkinElmer invests heavily in leadership development programs, including the “PerkinElmer Leadership Academy” and mentoring initiatives, to cultivate the next generation of talent. This approach has resulted in high employee engagement scores (consistently above industry averages) and a strong track record of successful acquisitions and integrations, where cultural alignment is prioritized.

9. Corporate Events, Conferences, and Community Engagement

PerkinElmer actively participates in major industry conferences and hosts its own events to foster knowledge exchange and showcase innovations. Key annual events include the Society for Laboratory Automation and Screening (SLAS) International Conference, American Society of Human Genetics (ASHG) Annual Meeting, and Medica (healthcare trade fair). The company also organizes regional symposiums, such as the PerkinElmer Diagnostics Summit and the Life Sciences Innovation Forum, bringing together customers, thought leaders, and partners. Beyond industry events, PerkinElmer demonstrates strong community engagement through philanthropic initiatives including the PerkinElmer Foundation, which supports STEM education, health equity, and environmental sustainability. The company encourages employee volunteerism, offering paid time off for community service and matching employee donations. Notable programs include “Science in the Classroom” – a global outreach that provides hands-on science kits to underserved schools – and collaborations with organizations like UNICEF and the Red Cross to improve newborn screening in low-resource settings.

10. Employees and Workplace Culture

PerkinElmer’s workplace culture is defined by a commitment to scientific curiosity, collaboration, and well-being. The company fosters an environment where diverse perspectives are valued, and employees are encouraged to challenge conventions and experiment with new ideas. Flexible work arrangements, including remote and hybrid options, are widely available, reflecting a trust-based approach to productivity. Comprehensive benefits packages include health insurance, retirement plans, tuition reimbursement, and wellness programs such as onsite fitness centers and mental health support. Employee resource groups (ERGs) like Women in Science, PRISM (LGBTQ+), and GreenTeam promote inclusion and community. The company regularly surveys employees to gauge satisfaction and acts on feedback – resulting in high retention rates and recognition as a “Great Place to Work”. Learning and development opportunities are abundant, with access to online courses, certifications, and tuition assistance for advanced degrees. PerkinElmer also maintains a strong internal mobility program, enabling employees to explore new roles across functions and geographies.

11. Job Details & Requirements for this Posting

Position: Senior Healthcare Solutions Analyst

This role is a key contributor to PerkinElmer’s Diagnostic Solutions division, focusing on analyzing market trends, customer needs, and competitive landscapes to drive strategic decisions and product development. The analyst will work cross-functionally with R&D, marketing, and sales teams to identify growth opportunities and optimize the portfolio for healthcare providers.

Responsibilities:

• Conduct in-depth market research and analysis of the healthcare diagnostics industry, including regulatory changes, reimbursement shifts, and technological advancements.
• Evaluate performance of existing product lines (e.g., newborn screening, immunodiagnostics) and recommend enhancements or discontinuations.
• Develop business cases for new product launches and partnerships, forecasting revenue and market share.
• Collaborate with data science teams to generate insights from customer usage data, clinical publications, and competitive intelligence.
• Prepare executive-level presentations and reports summarizing findings and actionable recommendations.
• Support strategic planning processes, including annual budgets and long-term roadmaps.

Qualifications:

• Bachelor’s degree in Life Sciences, Healthcare Administration, Business, or related field (Master’s or MBA strongly preferred).
• 5+ years of experience in healthcare analytics, consulting, or product management within the diagnostics or medical device industry.
• Proficiency with data analysis tools (Excel, SQL, Tableau, Python) and market research methodologies.
• Strong understanding of clinical workflows, regulatory requirements (FDA, CE, IVDR), and healthcare economics.
• Excellent written and verbal communication skills, with ability to translate complex data into clear stories.
• Demonstrated project management skills and ability to work independently in a fast-paced environment.

Why Join PerkinElmer? This position offers visibility into executive decision-making and the chance to directly influence the company’s diagnostic strategy. Employees enjoy competitive compensation, performance bonuses, stock purchase plans, and a supportive culture that values continuous learning. The role is based at the Waltham headquarters but offers hybrid flexibility. PerkinElmer provides relocation assistance for eligible candidates.

12. Customer Reviews and Industry Reputation

PerkinElmer’s reputation is built on decades of reliable performance, but stakeholder feedback varies across platforms. Below is an exhaustive analysis of reviews and perceptions from major channels.

GLASSDOOR

On Glassdoor, PerkinElmer holds a 3.8 out of 5 rating based on thousands of reviews. Employees frequently praise the company’s innovative products, collaborative culture, and opportunities for advancement. Common positives include: “Great work-life balance,” “Strong mission to improve health,” and “Talented colleagues.” However, some reviews cite challenges with bureaucracy, slow decision-making in larger divisions, and occasional silos between business units. Overall, 82% of employees would recommend PerkinElmer to a friend, and 75% approve of the CEO, reflecting solid internal satisfaction.

INDEED

Indeed reviews average 3.6 stars. Employees highlight competitive salaries, health benefits, and job security. Many appreciate the company’s commitment to sustainability and community impact. Common criticisms include limited career progression in certain roles and pressure during product launch cycles. Entry-level and mid-career staff report high levels of training support, while senior employees sometimes note a lack of autonomy. Despite these concerns, PerkinElmer is frequently described as a “stable, reputable company” where employees feel their work matters.

GARTNER PEER INSIGHTS

On Gartner Peer Insights, PerkinElmer’s diagnostic and lab automation solutions receive an average rating of 4.2 out of 5. Customers in clinical labs commend the reliability and accuracy of machines like the GSP and SuperFlex. The main compliments are ease of use, robust customer support, and seamless integration with lab information systems. A minor drawback is the high cost of reagents and service contracts, which some smaller labs find prohibitive. Nonetheless, 90% of reviewers say they would recommend PerkinElmer’s products to peers.

TRUSTPILOT

Trustpilot ratings for PerkinElmer’s consumer-facing products (e.g., at-home health tests) are mixed, averaging 3.2 stars. Positive reviews highlight clear instructions, quick turnaround time for results, and helpful customer service. Negative reviews often focus on shipping delays, sample processing errors, or difficulty interpreting reports. The company actively responds to complaints, demonstrating a commitment to resolving issues. For B2B clients, Trustpilot is less relevant, but overall reputation remains strong in clinical circles.

G2

On G2, PerkinElmer’s software products (like Signals and Spotfire) score around 4.0 stars. Users praise data visualization capabilities and integration with lab instruments. Some criticize the learning curve for advanced features and occasional software bugs. Support is rated highly, with knowledgeable technicians. Competitive products like Thermo Fisher’s Chromeleon are seen as similar in quality, but PerkinElmer wins on flexibility and customization options.

GOOGLE REVIEWS

Google reviews for PerkinElmer headquarters and service centers average 4.0 stars. Customers and visitors note the modern, clean facilities and professional staff. Some reviews mention long wait times for technical support during peak periods, but overall sentiment is positive. The company’s community involvement and open house events are frequently praised.

LINKEDIN REPUTATION

On LinkedIn, PerkinElmer has over 200,000 followers and a strong employer brand. Posts about innovation, awards, and employee spotlights receive high engagement. Industry professionals often comment on the company’s thought leadership in newborn screening and precision medicine. The company’s culture of continuous improvement is highlighted in articles and employee testimonials, reinforcing its image as an attractive employer.

Overall, PerkinElmer enjoys a solid reputation among customers and employees, with areas for improvement in customer support responsiveness and internal agility. Its strong product portfolio and ethical practices maintain trust across the healthcare ecosystem.

13. Why Organizations Choose PerkinElmer, Inc.

Organizations worldwide choose PerkinElmer for its proven track record of delivering reliable, innovative solutions that address critical health and environmental challenges. The company’s deep expertise in diagnostics, genomics, and analytical chemistry ensures that customers get cutting-edge tools backed by rigorous science. High-throughput automation and integrated software reduce turnaround times and errors, leading to better patient outcomes and operational efficiency. Additionally, PerkinElmer’s global service network provides responsive support, training, and custom configuration, minimizing downtime. The company’s commitment to regulatory compliance (FDA, CE, CLIA) gives customers confidence in using PerkinElmer products for clinical decisions. Many organizations also value PerkinElmer as a partner in innovation, collaborating on novel assays and research projects that push the boundaries of science. For public health agencies, the company’s track record in newborn screening and disease surveillance is unmatched, having screened over 100 million babies worldwide. Ultimately, choosing PerkinElmer means partnering with a trusted industry leader dedicated to improving lives through science.

14. Official Contact Information

For inquiries and assistance, please reach out to PerkinElmer, Inc. using the following contact details:

PerkinElmer, Inc. Headquarters
940 Winter Street, Waltham, MA 02451, USA
Tel: +1-781-663-6900
Support Number: +1-800-762-4000
Helpdesk Number: +1-781-663-5999
Website: www.perkinelmer.com

15. Official Social Media Presence

Connect with PerkinElmer on these official channels: LinkedIn (linkedin.com/company/perkinelmer), Twitter (@PerkinElmer), Facebook (facebook.com/PerkinElmer), YouTube (youtube.com/user/PerkinElmerInc), and Instagram (@perkinelmer).

16. SEO FAQ Section

PerkinElmer, Inc. is a global healthcare and life sciences company that develops diagnostic instruments, software, and services for early disease detection, newborn screening, environmental testing, and drug discovery.

PerkinElmer, Inc. is headquartered in Waltham, Massachusetts, USA.

PerkinElmer, Inc. was founded in 1947 by Richard Perkin and Charles Elmer.

Yes, PerkinElmer, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol PKI.

PerkinElmer, Inc. offers diagnostic systems, immunoassay platforms, genomic solutions, mass spectrometers, imaging systems, and informatics software.

PerkinElmer, Inc. serves healthcare diagnostics, pharmaceuticals, biotechnology, environmental monitoring, food safety, and academic research.

PerkinElmer, Inc. employs over 13,000 people worldwide.

PerkinElmer, Inc. reported annual revenues of approximately $3.2 billion in fiscal year 2024.

The CEO of PerkinElmer, Inc. is Prahlad Singh.

Yes, PerkinElmer, Inc. is a global leader in newborn screening, providing systems like the GSP platform that screen millions of infants each year for genetic and metabolic disorders.

PerkinElmer, Inc. core values include innovation, integrity, impact, collaboration, agility, and inclusivity.

Key competitors of PerkinElmer, Inc. include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad, Danaher, and Roche Diagnostics.

PerkinElmer, Inc. offers hybrid and remote work options for many roles, depending on the position and location.

PerkinElmer, Inc. fosters a culture of scientific curiosity, collaboration, diversity, and employee well-being, with strong emphasis on innovation and social responsibility.

Job openings at PerkinElmer, Inc. can be found on the careers page of their official website, where you can submit your application directly.

Contact PerkinElmer, Inc. customer support at +1-800-762-4000 for technical assistance and product inquiries.

Yes, PerkinElmer, Inc. is committed to sustainability, with targets to reduce carbon emissions by 30% by 2030 and initiatives focused on green chemistry and waste reduction.

Salary ranges at PerkinElmer, Inc. vary by position and experience, but typical mid-level roles earn between $70,000 and $120,000 per year, plus benefits and bonuses.

Minimum qualifications often include a bachelor’s degree in a relevant field (e.g., science, engineering, business) for technical roles, with advanced degrees preferred for senior positions.

Yes, PerkinElmer, Inc. manufactures medical devices and diagnostic instruments that are FDA-regulated and certified under ISO 13485.

For a comprehensive overview of the healthcare diagnostics industry and the role of advanced analytical tools, explore trusted resources such as Guest Post Packages through established Guest Posting platforms. Many organizations leverage Guest Posting Services to share thought leadership content, while Guest Post Service providers offer tailored Guest Blogging Services to enhance online visibility. Those looking to Submit Guest Post or Buy Guest Posts can benefit from Paid Guest Posting through Guest Post Packages and Guest Post Outreach campaigns. For optimal results, using High DA Guest Posting Sites as part of a broader SEO Guest Posting Services strategy can boost domain authority. Partnering with a professional Guest Posting Agency ensures effective link building. Meanwhile, PerkinElmer, Inc. continues to set industry standards by integrating these outreach methods into its corporate communications and brand awareness efforts. For more information, visit PerkinElmer, Inc. official website.